Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-12-01, Stock:PFE, The news for the past five days is as follows:
2021-11-23: NEWS1: Will Pfizer ETFs Soar on Positive COVID-19 Vaccine Updates?.NEWS2: COVID-19 vaccines have ‘proved their merit at this point’: Doctor.NEWS3: Countries pushing vaccine IP waivers ‘want to take advantage of the technology’: Fmr. U.S. Commerce Secretary.NEWS4: COVID-19: The U.S. issues advisory for travel to Europe but has no plans for a lockdown.NEWS5: COVID-19: The U.S. issues advisory for travel to Europe but has no plans for a lockdown.NEWS6: Covid-19 Vaccine and Pills Will Push Pfizer’s Revenue Above $100B Next Year, Analyst Says.NEWS7: 4 Reasons Pfizer Is Now the Ultimate COVID-19 Growth Stock.NEWS8: Ukraine to buy 25 mln Pfizer vaccine doses a year over 2022-23.NEWS9: Why FDA Boosters Authorization Could Be More Important for Pfizer and Moderna Than You Might Think.
2021-11-24: NEWS1: COVID-19: ‘Vaccines absolutely decrease the risk of transmission’, doctor says.NEWS2: Pfizer sues departing employee it says stole COVID-19 vaccine secrets.NEWS3: Germany mulls a lockdown as COVID cases rise in Europe.NEWS4: Got $5,000? 2 Stocks to Buy and Hold Forever.NEWS5: Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference.NEWS6: Pfizer (PFE) COVID Vaccine & Pill Drive Stock Up This Year.NEWS7: How This News May Represent a Crucial Test for Moderna and Pfizer.
2021-11-26: NEWS1: Covid Testing Company Says PCR Tests Are Effective Against New Covid Variant.NEWS2: Moderna to 'rapidly advance' omicron-specific COVID-19 booster candidate.NEWS3: Stock market news live updates: Wall Street rocked by new COVID variant fears, Dow plunges over 900 points.NEWS4: U.S., Canada Follow Europe on Africa Travel Ban: Virus Update.NEWS5: A New Covid Variant Is Triggering Travel Restrictions Worldwide. What to Know..NEWS6: 4 Reasons Why You Should Add Sarepta (SRPT) to Your Portfolio.NEWS7: Market strategists split on 'buying opportunity' after post-Thanksgiving selloff.NEWS8: Dow Jones Dives As New Covid Variant Emerges; Moderna Erupts; This Warren Buffett Stock Rebounds.NEWS9: Pfizer’s Pill, Shot Push Stock to Record as Variant Emerges.NEWS10: IBD Stock Of The Day Pfizer Breaks Out As Scientists Contend With New Variant.NEWS11: What the newly discovered COVID-19 variants means for investors: Stifel chief equity strategist.NEWS12: Qiagen Rises as It Reaffirms PCR Tests’ Effectiveness in Light of New Covid Variant.NEWS13: A Terrifying New Variant Could Elude Vaccines — BioNTech Won't Know For Two Weeks.NEWS14: Merck Slumps on Covid Pill’s Lower Efficacy, FDA Scrutiny.NEWS15: Merck’s Covid-19 Pill Was 30% Effective in Final Analysis, Company Says.NEWS16: Zoom, Peloton and Moderna Stocks Surge. Why the Stay-at-Home Trade Is Back..NEWS17: Vaccines 'still the backbone of everything we do' amid any variants, doctor explains.NEWS18: Market selloff: COVID-19 news 'caught people by surprise' on shortened day, strategist explains.NEWS19: Stocks fall, Merck drops on COVID-19 pill effectiveness, air travel hits pandemic high, more PPP fraud.NEWS20: Airlines and cruises take a hit, Zoom and vaccine stocks up.NEWS21: Hospital capacity is key for COVID-19 containment going forward: Oppenheimer analyst.NEWS22: 'Travel bans don't work,' doctor explains amid reports of newly discovered variant.NEWS23: Market strategist details 'the critical issue' to understand about risk from new COVID-19 variant.NEWS24: Stocks down after discovery of new COVID-19 variant.NEWS25: UPDATE 2-BioNTech says it expects more data on new variant in two weeks.NEWS26: BioNTech says expect more data on new variant in 2 weeks.NEWS27: Pfizer/BioNTech's COVID Jab Gets CHMP Nod for Kids Aged 5-11.NEWS28: Pharma Stock Roundup: FDA Nod to COVID Jab for All Adults, CHMP Nod to Shot for Kids.NEWS29: Nervy Week for Markets Ends With Wild Swings on New Covid Strain.NEWS30: Zoom Video Stock and Moderna Surge Amid New Covid-19 Variant Fears.NEWS31: With the Virus Still in Charge, Pfizer Can Be Flexible: Here's My Plan.NEWS32: Pfizer Stock Hits Record High, Moderna Surges On New Covid Variant Discovery.NEWS33: American Airlines, Goldman Sachs, Exxon Mobil Fall Premarket; Peloton, Zoom Rise.NEWS34: Merck Gives Up Gains Ahead of FDA Review of Covid-19 Pill.NEWS35: Pfizer Stock Leaps, Moderna Surges On New Covid Variant Discovery.NEWS36: Covid Variant Slams Stocks, Black Friday Clouded By Concerns - 5 Things You Must Know.
2021-11-29: NEWS1: Merck Shares Fall Ahead of FDA Hearing on Covid Pill.NEWS2: Doctor explains Omicron and the possibility of more COVID-19 variants.NEWS3: US STOCKS-Wall Street rebounds after virus-related sell-off.NEWS4: UPDATE 4-U.S. CDC says all adults should get COVID-19 booster shots.NEWS5: Merck Gives Up 2021 Gains Ahead of Covid Pill Panel Review.NEWS6: 10 Safe Dividend Stocks to Invest In.NEWS7: Omicron stock market rout doesn't mean stocks are a 'screaming' buy: strategist.NEWS8: Cramer's Mad Money Recap 11/29: Omicron, Amazon,  Netflix.NEWS9: Key takeaways from President Biden's comments on new COVID-19 variant.NEWS10: Omicron Fears Fuel Rally in Vaccine Stocks: Will It Continue?.NEWS11: Omicron: What we know so far about the new COVID-19 variant.NEWS12: Omicron variant may mean stock market rally is on hold: Goldman Sachs.NEWS13: Omicron Variant Has Covid-19 Vaccine Makers Preparing for Worst Case.NEWS14: Omicron variant: ‘There probably are cases’ in the U.S. but not yet in large numbers, professor says.NEWS15: ETF Areas to Gain/Lose on Fear of Omicron Strain of Coronavirus.NEWS16: Merck stock dives after Citi downgrades on ‘high probability’ that HIV treatment will be abandoned.NEWS17: Dow Jones Jumps 300 Points As Stock Market Rebounds From Friday Rout.NEWS18: Rep. Perlmutter (D-CO) talks COVID, Build Back Better bill, the debt ceiling, and marijuana reform.NEWS19: BioNTech, Pfizer, J&J and Moderna Developing Omicron Vaccines.NEWS20: Another COVID wave could depress consumer spending, labor force participation: Economist.NEWS21: Deciphera (DCPH) Down More Than 70% in Past 3 Months: Here's Why.NEWS22: Omicron variant: The U.S. travel ban ‘makes no sense at all,’ doctor says.NEWS23: Vaccine Stocks Could Win Now, Lose Later, From the Omicron Variant.NEWS24: COVID: 'The big concern is Delta — Omicron is not even here yet,' epidemiologist says.NEWS25: Dow Jones Up As Apple, Microsoft Lead; EV Stocks Rally As Market Rebounds From Covid Sell-Off.NEWS26: Cyber Monday to Determine Holiday Sales Fate.NEWS27: Market check: Stocks recoup some losses after Friday’s sell-off.NEWS28: The Omicron variant ‘could lead to more volatile days ahead,’ strategist says.NEWS29: Will Cyber Monday Rescue Holiday Shopping from Omicron Fears?.NEWS30: Elizabeth Holmes cross-examination: 'The devil will be in the details'.NEWS31: BioNTech, Moderna, J&J Explore Omicron Versions of Shots.NEWS32: NRx Soars as Drug Benefits Remdesivir-Treated Covid Patients.NEWS33: COVID: Breaking down early data on Omicron variant.NEWS34: UPDATE 1-Pfizer now expects to produce 80 mln courses of COVID-19 pill, CEO tells CNBC.NEWS35: Dow Jones Futures Signal Market Rally After Omicron Covid Sell-Off, Moderna, Tesla Rival Li Auto Jump.NEWS36: Pfizer expects to produce 80 mln courses of COVID-19 antiviral pill - CNBC reporter tweet.NEWS37: Merck (MRK) COVID Pill Less Effective in Final Study, Stock Down.NEWS38: The Omicron variant and the stock market: Morning Brief.NEWS39: Confused about whether to get a COVID booster? Here’s what to know.NEWS40: Pfizer Stock Jumps On Plan To Boost Covid Pill Production In Fight Against Omicron Variant.NEWS41: Moderna Stock Surges As Drugmaker Says It Can Have Omicron Vaccine Ready in Early 2022.
2021-11-30: NEWS1: UPDATE 1-Pfizer seeks U.S. authorization of COVID-19 booster shots for 16, 17 year olds.NEWS2: Merck Stock Inches Higher After FDA Advisors Narrowly Recommend Covid Pill.NEWS3: Omicron threat in the U.S: 'We can presume it's here,' physician says.NEWS4: U.S. administers 460.7 mln doses of COVID-19 vaccines - CDC.NEWS5: FDA advisers recommend Merck’s COVID-19 pill in close vote.NEWS6: Omicron Risks Infecting Vaccinated People but May Not Cause Them Severe Illness.NEWS7: Pfizer Has Best Month in 30 Years After Leading Vaccine Race.NEWS8: Merck Stock In Limbo As FDA Advisors Consider Covid Pill As Omicron Looms.NEWS9: Adagio Continues Its Run As Biotech Stocks Moderna, BioNTech Dive On Omicron Threat.NEWS10: Why Novavax and Pfizer Are Trouncing the Market Today.NEWS11: Analysis: As Omicron plays havoc with markets, shares of vaccine makers surge.NEWS12: Moderna CEO says vaccines likely less effective against Omicron COVID-19 variant.NEWS13: Omicron: 'Time will tell' as we learn more about transmissibility and risk, doctor explains.NEWS14: 'The market doesn't like an information vacuum, and now we have two,' strategist says.NEWS15: Top Research Reports for Mastercard, Pfizer & Nike.NEWS16: Dow Jones Dives 650 Points After Fed's Powell Comments; Omicron Fears Spread.NEWS17: 10 Biotech Penny Stocks to Buy Now.NEWS18: Pfizer, BioNTech to Seek Booster Approval for 16- and 17-Year Olds.NEWS19: Theranos founder Elizabeth Holmes to face cross-examination at fraud trial.NEWS20: UPDATE 3-U.S. FDA panel narrowly backs Merck's at-home COVID-19 pill.NEWS21: FDA advisers to vote Tuesday on Merck’s COVID-19 pill even as interest has waned.NEWS22: Pfizer and BioNTech to Seek Covid Booster Approval for 16- and 17-Year-Olds.NEWS23: Dow Jones Drops As Covid Variant Fears Hit Stocks, Nasdaq Swings Up, Down.NEWS24: Merck's (MRK) Keytruda Gets Europe Nod for Two Carcinomas.NEWS25: Moderna (MRNA) Rallies on Booster Hopes Amid Omicron Concerns.NEWS26: ‘We can’t have countries lingering at 10%' COVID-19 vaccination, Columbia professor explains.NEWS27: Dow Jones Sells Off As Moderna CEO Expects Less Effective Vaccines For Omicron Variant.NEWS28: J&J (JNJ) to Explore Omicron Version of its COVID Vaccine.NEWS29: Stocks fall as investors try to gauge Omicron risk, ongoing supply chain issues.NEWS30: Market strategist: Investors ‘don’t want to overreact’ amid Omicron uncertainty.NEWS31: Dow Jones Futures Sell Off As Moderna CEO Expects Less Effective Vaccines For Omicron Variant.NEWS32: Merck’s Covid Pill Gets an FDA Hearing. What’s at Stake for the Stock..NEWS33: GlaxoSmithKline poaches Pfizer’s vaccine chief after Covid jab failure.NEWS34: The Zacks Analyst Blog Highlights: Pfizer, BioNTech, Moderna and Novavax.NEWS35: GSK names Pfizer scientist Dormitzer as vaccines R&D head.NEWS36: Dow Jones Futures Dive As Moderna CEO Predicts Less Effective Vaccines For Omicron Variant.NEWS37: Is This Leading COVID Stock a Buy Right Now?.NEWS38: Don’t hesitate, get a COVID booster now: epidemiologist urges.NEWS39: Two Israeli doctors infected with Omicron, hospital says.NEWS40: U.S. FDA panel to weigh Merck's COVID-19 antiviral drug.NEWS41: European markets fall as Moderna boss says vaccine less effective against Omicron.NEWS42: Moderna Stock Slumps, Regeneron Slides On Omicron Variant Efficacy Warnings.NEWS43: Oil Heads for the Worst Monthly Loss This Year on Omicron Scare.NEWS44: Why We Shouldn't Write Off Omicron Cases as ‘Mild’.NEWS45: Dow Jones Futures: Stock Market Rebounds As Biden Rules Out New Lockdowns; Rivian, Tesla Race Higher.

Answer: Rise